← Back to Search

Flavonoids

Elderberry for Coronavirus

N/A
Waitlist Available
Research Sponsored by Franklin Health Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 13 weeks

Summary

This trial is testing whether taking elderberry extract capsules can help improve immune health. The study involves people who might get upper respiratory issues like colds. The elderberry extract has natural compounds that could boost the immune system and help fight infections. Elderberry extract has been traditionally used to treat respiratory problems and has shown potential in reducing the duration and severity of colds and influenza.

Eligible Conditions
  • Coronavirus
  • Influenza
  • Flu
  • Common Cold
  • Cold

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~13 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 13 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Duration of Upper Respiratory Events
Incidence of Upper Respiratory Events
Incidence of Upper Respiratory Symptomatic Days
+1 more
Secondary study objectives
Cognitive Wellbeing
Duration of COVID-19
Duration of influenza
+7 more
Other study objectives
Adverse Events
Digestive Health

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Intervention ArmExperimental Treatment1 Intervention
Participants will receive a 13-week supply of ElderCraft® (European black elderberry extract standardized to 15% anthocyanins). Each capsule contains 300mg of extract; participants will take a total of two capsules each day.
Group II: Placebo ArmPlacebo Group1 Intervention
Participants will receive a 13-week supply of inert placebo capsules matched for polysaccharide content. Participants will take a total of two capsules each day.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Elderberry
2011
N/A
~80

Find a Location

Who is running the clinical trial?

Artemis InternationalUNKNOWN
1 Previous Clinical Trials
57 Total Patients Enrolled
Franklin Health ResearchLead Sponsor
16 Previous Clinical Trials
3,089 Total Patients Enrolled
IPRONAUNKNOWN
~133 spots leftby Nov 2025